ref_name,rx_name,control_iso_name,iso_name,ordinal_number,section,fold_cmp,fold,potency_type,resistance_level,ineffective,cumulative_count,assay,date_added
Copin21,Casirivimab,S:614G,B.1.1.7 Spike,1,Figure1B,=,1.2,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,B.1.1.7 Spike,1,Figure1B,=,0.7,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,B.1.1.7 Spike,1,Figure1B,=,0.9,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,B.1.351 Spike,1,Figure1B,=,45,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,B.1.351 Spike,1,Figure1B,=,0.14,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,B.1.351 Spike,1,Figure1B,=,0.6,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,P.1 Spike,1,Figure1B,=,143,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,P.1 Spike,1,Figure1B,=,0.7,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,P.1 Spike,1,Figure1B,=,0.14,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,S:484K,1,Figure1B,=,15,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,S:484K,1,Figure1B,=,1.2,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,S:484K,1,Figure1B,=,1.6,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,S:452R,1,Figure1B,=,1.3,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,S:452R,1,Figure1B,=,1.1,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,S:452R,1,Figure1B,=,1.2,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,S:446V,1,Figure S3,=,0.4,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,S:446V,1,Figure S3,=,135,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,S:446V,1,Figure S3,=,0.5,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,S:477N,1,Figure S3,=,2.9,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,S:477N,1,Figure S3,=,2.3,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,S:477N,1,Figure S3,=,1.9,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,S:494P,1,Figure S3,=,4.5,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,S:494P,1,Figure S3,=,1,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,S:494P,1,Figure S3,=,1.1,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,S:501Y,1,Figure S3,=,0.9,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,S:501Y,1,Figure S3,=,0.5,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,S:501Y,1,Figure S3,=,1.1,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,S:537R,1,Figure S3,=,1.1,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,S:537R,1,Figure S3,=,0.8,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,S:537R,1,Figure S3,=,1,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,S:384L,1,Figure S3,=,1.9,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,S:384L,1,Figure S3,=,1.3,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,S:384L,1,Figure S3,=,1.7,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,S:444T,1,Figure S3,=,2,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,S:444T,1,Figure S3,=,1032,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,S:444T,1,Figure S3,=,6.4,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,S:445A,1,Figure S3,=,1.9,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,S:445A,1,Figure S3,=,548,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,S:445A,1,Figure S3,=,4.7,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,S:455F,1,Figure S3,=,79,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,S:455F,1,Figure S3,=,1.1,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,S:455F,1,Figure S3,=,1.8,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,S:486L,1,Figure S3,=,61,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,S:486L,1,Figure S3,=,0.9,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,S:486L,1,Figure S3,=,1.5,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab,S:614G,S:486V,1,Figure S3,=,438,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Imdevimab,S:614G,S:486V,1,Figure S3,=,0.9,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
Copin21,Casirivimab+Imdevimab,S:614G,S:486V,1,Figure S3,=,2.7,IC50,NULL,NULL,1,vsv pseudovirus,2021-03-13
